Patents by Inventor Dean S. Wise

Dean S. Wise has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7144995
    Abstract: A fluorescent nitrogenous base and nucleosides including the fluorescent nitrogenous base are provided. Nucleosides including the fluorescent nitrogenous base are capable of Watson-Crick base pairing with naturally occurring nucleosides. The nucleosides including the fluorescent nitrogenous base have many uses including but not limited to use in probes, in the synthesis of nucleic acids, and in investigating nucleic acid interactions with other nucleic acids and/or with proteins.
    Type: Grant
    Filed: March 6, 2003
    Date of Patent: December 5, 2006
    Assignees: Glen Research Corporation, Berry & Associates
    Inventors: Dean S. Wise, Anthony D. Sercel, Kee-Yong Jung, David A. Berry, John B. Randolph, Robert L. Somers, Hugh Mackie
  • Publication number: 20040009933
    Abstract: A fluorescent nitrogenous base and nucleosides including the fluorescent nitrogenous base are provided. Nucleosides including the fluorescent nitrogenous base are capable of Watson-Crick base pairing with naturally occurring nucleosides. The nucleosides including the fluorescent nitrogenous base have many uses including but not limited to use in probes, in the synthesis of nucleic acids, and in investigating nucleic acid interactions with other nucleic acids and/or with proteins.
    Type: Application
    Filed: March 6, 2003
    Publication date: January 15, 2004
    Applicants: Glen Research Corporation, Berry & Associates
    Inventors: Dean S. Wise, Anthony D. Sercel, Kee-Yong Jung, David A. Berry, John B. Randolph, Robert L. Somers, Hugh Mackie
  • Patent number: 5278181
    Abstract: Soluble alkyl [5-(amino (phenyl)methyl)-2H-benzimidazol-2-yl]carbamates, their enantiomorphic forms, and acid addition salts thereof are well absorbed and possess curative anthelmintic activity, especially against filarial worms, when administered orally or parenterally. Pharmaceutical compositions containing the compounds and methods of employing the compounds in methods of treating helminth infections in mammals are also disclosed, together with methods of synthesis.
    Type: Grant
    Filed: May 12, 1992
    Date of Patent: January 11, 1994
    Assignee: Board of Regents Acting on Behalf of the University of Michigan
    Inventors: Leroy B. Townsend, Dean S. Wise, Siya Ram